Wave life sciences ltd. (WVE)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flows from operating activities
Net loss

-196,931

-193,638

-174,755

-161,660

-155,612

-146,653

-139,559

-127,422

-116,125

-101,980

-89,900

-81,941

-68,909

-55,660

-44,046

-31,447

-23,582

-19,200

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of lease incentive obligation

-

-

-

-

-

790

578

411

298

208

0

0

0

-

-

-

-

-

-

-

-

Amortization of right-of-use assets

1,674

1,613

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation of property and equipment

7,856

7,600

7,317

6,828

6,208

5,600

4,801

3,938

3,060

2,200

1,525

1,118

946

784

657

753

658

594

0

0

0

Share-based compensation expense

19,163

19,509

18,533

17,123

15,511

15,596

14,762

14,152

13,574

12,143

11,494

10,677

8,980

6,847

5,133

3,668

3,044

4,024

0

0

0

Net loss on disposal of property and equipment

-

-

-

-

-

-44

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

973

1,287

2,080

2,950

3,594

3,401

2,495

1,460

565

463

345

254

88

0

0

0

Deferred income taxes

-

-

-

-

-

-

-

-

-

908

28

-609

-886

-698

32

-20

-19

36

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

0

-

-

-

-

59,000

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

Prepaid expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

0

0

4,174

-

4,758

1,611

2,736

1,337

296

1,921

234

-130

0

0

0

Other assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current assets

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

Accounts payable

3,056

-3,497

9,606

4,288

5,329

4,936

6,069

1,895

3,265

3,892

2,094

3,871

4,682

3,369

1,083

1,118

1,103

1,648

0

0

0

Accrued expenses and other current liabilities

2,724

1,448

4,219

3,529

1,938

5,864

3,299

3,617

2,546

4,550

1,710

1,252

1,430

2,296

2,824

1,830

847

267

0

0

0

Deferred revenue

-17,118

-15,983

-17,205

-18,768

158,981

160,585

164,109

167,286

-3,932

-2,893

0

0

0

-

-

-

-

-152

0

0

0

Operating lease liabilities

-2,918

-2,816

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

-418

-421

298

364

434

523

474

-537

-450

823

1,102

2,147

2,128

864

0

0

0

-

-

-

-

Net cash used in operating activities

-164,100

-188,231

-159,811

-145,140

-40,817

-22,862

-12,796

-7,197

-98,679

-83,671

-74,264

-62,685

-42,207

-31,925

-25,246

-16,262

-18,044

-12,527

0

0

0

Increase in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,055

0

0

0

Purchases of property and equipment

3,990

3,918

6,035

8,959

9,282

9,938

10,554

12,771

16,416

18,887

17,537

13,206

8,517

5,567

3,808

3,042

2,525

1,857

0

0

0

Net cash used in investing activities

-3,990

-3,918

-6,035

-8,959

-9,282

-9,938

-10,554

-12,771

-16,416

-18,887

-17,537

-13,206

-8,513

-5,563

-3,804

-3,038

-3,522

-2,909

0

0

0

Cash flows from financing activities
Payments on capital lease obligation

-

-

-

-

-

16

31

47

62

62

62

62

62

62

0

0

0

-

-

-

-

Proceeds from the exercise of share options

1,136

2,607

2,496

3,594

5,038

5,110

5,068

3,797

2,274

927

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,467

164,399

164,288

165,386

227,103

65,094

65,037

63,745

95,721

94,374

93,800

93,925

29,327

29,121

131,842

192,869

163,946

175,593

0

0

0

Effect of foreign exchange rates on cash, cash equivalents and restricted cash

23

114

101

209

91

37

350

270

389

403

3

146

29

-14

183

417

56

15

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

-166,600

-27,636

-1,457

11,496

177,095

32,331

42,037

44,047

-18,985

-7,781

2,002

18,180

-21,364

-8,381

102,975

173,986

142,436

160,172

0

0

0

Supplemental disclosure of cash flow information:
Deferred follow-on offering costs in accounts payable and accrued expenses at period end

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for taxes, net of refunds

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Property and equipment purchases in accounts payable and accrued expenses at period end

-

-

-

-

-

-

-

-

-

-

0

0

4,444

-

0

0

0

-

-

-

-

Tenant improvements paid for by the landlord during the period

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

At-The-Market Equity Program [Member]
Proceeds from issuance of ordinary shares, net of offering costs

331

161,792

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

11,631

0

0

0